[Evolution of DFU treatment strategies: from simple coverage with traditional dressings to active modulation with smart materials]. [PDF]
Chen XL.
europepmc +1 more source
[Fibroblast growth factor 21 improves alcoholic liver disease by regulating gut microbiota in mice]. [PDF]
Wu GC +5 more
europepmc +1 more source
[A case of neonatal fatty acid oxidation disorder]. [PDF]
Deng LL +4 more
europepmc +1 more source
[Liraglutide improves cardiac structure and function in mice with advanced diabetic nephropathy and massive proteinuria]. [PDF]
Yan Y +5 more
europepmc +1 more source
[Natural history and risk factors of metabolic associated fatty liver disease in Chinese cohorts]. [PDF]
Zhang J, Zhan RX, Wang Y, Nan YM.
europepmc +1 more source
[Construction norms for the tiered diagnosis and treatment and standardized management center of metabolic-associated fatty liver disease]. [PDF]
Fatty Liver and Alcoholic Liver Disease Study Group +2 more
europepmc +1 more source
[Effects of astragaloside Ⅰ on full-thickness skin defects in diabetic rats and its underlying mechanism]. [PDF]
Li Y +5 more
europepmc +1 more source
[Influence and mechanism of PBNP combined with mouse ADSCs on full-thickness skin defect wounds in diabetic mice]. [PDF]
Zhang XW, Xu SY, Han YJ, Li XM, Xu G.
europepmc +1 more source
[Research progress on immune microenvironment imbalance and targeted interventions in osteoarthritis comorbid with diabetes mellitus]. [PDF]
Sun Y, Yang Y.
europepmc +1 more source
[How I treat anaphylaxis in children]. [PDF]
Xie M, Wang X.
europepmc +1 more source

